首页> 外文期刊>International Journal of Pharmacology >Diagnostic Values of Urinary Biomarkers in Early Diagnosis of Diabetic Nephropathy
【24h】

Diagnostic Values of Urinary Biomarkers in Early Diagnosis of Diabetic Nephropathy

机译:尿液生物标志物在糖尿病肾病早期诊断中的诊断价值

获取原文
       

摘要

Background and Objective: The diagnosis of type 2 diabetic nephropathy (T2DN) patients is important to prevent the long-term damaging effects of kidney loss in patients with diabetes. The aim of this study was to explore diagnostic values of Urinary RBP levels, NGAL, ZAG and urinary transferrin in early diagnosis of diabetic nephropathy. Materials and Methods: The total sample size was comprised of 400 patients, 300 subjects were of type 2 diabetes mellitus and 100 subjects were considered under the control subjects without any systemic illness. According the ratio of urine and albumin urine creatinine, subjects were further divided into 3 sub-categories: normoalbuminuria, microalbuminuria and macroalbuminuria group. Human ELISA kit had been used for the evaluation of Urine urinary RBP, NGAL, Adipokine zinc-alpha-2-glycoprotein and urinary transferring. Results: The level of u-NCR, u-RCR, u-ZCR, u-TCR levels in the macroalbuminuria and microalbuminuria were markedly and significantly high when compared with normoalbuminuria and control subjects. So, when the stages of diabetic nephropathy are going critical, the levels of all the biomarkers also increasing in their value. urinary transferrin and RBP have excellent diagnostic accuracy with AUC = 1-0.9. Conclusion: This study concluded that the evaluation of urinary RBP, NGAL, ZAG and urinary transferrin could be use as novel and accurate biomarker for the early diagnosis , clinical monitoring and progression of diabetic nephropathy patients.
机译:背景与目的:2型糖尿病肾病(T2DN)患者的诊断对于预防糖尿病患者肾丢失的长期破坏作用具有重要意义。这项研究的目的是探讨尿RBP水平,NGAL,ZAG和尿转铁蛋白在糖尿病肾病的早期诊断中的诊断价值。材料和方法:总样本量为400例患者,其中300例为2型糖尿病患者,100例为无系统性疾病的对照组。根据尿液和白蛋白尿肌酐的比例,将受试者进一步分为三个子类别:正常白蛋白尿,微量白蛋白尿和大型白蛋白尿组。人类ELISA试剂盒已用于评估尿中尿RBP,NGAL,脂肪因子锌-α-2-糖蛋白和尿转移。结果:与正常白蛋白尿和对照组相比,巨白蛋白尿和微量白蛋白尿中的u-NCR,u-RCR,u-ZCR,u-TCR水平显着和显着较高。因此,当糖尿病肾病的阶段变得很关键时,所有生物标志物的水平也会增加其价值。尿运铁蛋白和RBP在AUC = 1-0.9时具有出色的诊断准确性。结论:本研究的结论是,尿中RBP,NGAL,ZAG和尿中转铁蛋白的评估可作为糖尿病肾病患者早期诊断,临床监测和进展的新型,准确的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号